Publisher
Springer Science and Business Media LLC
Reference130 articles.
1. Michalek IM, Loring B, John SM. Global report on psoriasis. Geneva: World Health Organization; 2016.
2. Kolli SS, Amin SD, Pona A, Cline A, Feldman SR. Psychosocial impact of psoriasis: a review for dermatology residents. Cutis. 2018;102(5S):21–5.
3. Stanke-Labesque F, Gautier-Veyret E, Chhun S, Guilhaumou R, French Society of Pharmacology and Therapeutics. Inflammation is a major regulator of drug metabolizing enzymes and transporters: consequences for the personalization of drug treatment. Pharmacol Ther. 2020;215:107627.
4. Morales Castro D, Dresser L, Granton J, Fan E. Pharmacokinetic alterations associated with critical illness. Clin Pharmacokinet. 2023;62(2):209–20.
5. Ho VC, Griffiths CE, Berth-Jones J, Papp KA, Vanaclocha F, Dauden E, et al. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study. J Am Acad Dermatol. 2001;44(4):643–51.